Chemed CHE
NYSE CHE
$524.42 +0.43 (+0.08%)
As of: Sep 3, 2026 · 3:59 PM EDT

Chemed (CHE) Restructuring Costs (2012 - 2013)

Chemed (CHE) posted quarterly Restructuring Costs of $10.5 million for Q3 2013, up 832.5% year-over-year from $1.1 million in Q3 2012, and up 832.5% on a QoQ basis from $1.1 million in Q3 2012.

Analysis

Chemed (CHE) Restructuring Costs (2012 - 2013) Analysis & Trends

Chemed has reported Restructuring Costs for 2 years, with the latest figure at $10.5 million in Q3 2013.

  • Restructuring Costs for Q3 2013 came in at $10.5 million, up 832.5% year-over-year; the trailing twelve-month figure through Dec 2013 was $11.6 million (changed N/A YoY), and the FY2013 annual result was $15.7 million, up 1296.18% from the prior year.
  • Restructuring Costs rose to $10.5 million in Q3 2013, from $1.1 million in the prior quarter.
  • Over five years, Restructuring Costs peaked at $10.5 million in Q3 2013 and troughed at $1.1 million in Q3 2012.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 90.36 Bn 89.35 Bn 15.19 Bn
2 Tenet Healthcare 22.02 Bn 19.85 Bn 4.45 Bn
3 Encompass Health 12.13 Bn 11.99 Bn 1.34 Bn
4 Davita 11.78 Bn 11.09 Bn 1.16 Bn
5 Universal Health Services 10.09 Bn 9.95 Bn 3.29 Bn
6 Ensign 9.97 Bn 9.65 Bn 306.24 Mn
7 Chemed 6.93 Bn 6.89 Bn 221.47 Mn
8 Pacs 6.81 Bn 6.64 Bn 338.46 Mn
9 Concentra Group Holdings Parent 4.32 Bn 4.16 Bn 192.10 Mn
10 Option Care Health 3.74 Bn 3.55 Bn 267.25 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2013 10.50 Mn
Sep 30, 2012 1.13 Mn